Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.475
+0.125 (2.87%)
Mar 6, 2026, 10:03 AM EST - Market open
Bolt Biotherapeutics Employees
Bolt Biotherapeutics had 52 employees as of December 31, 2024. The number of employees decreased by 48 or -48.00% compared to the previous year.
Employees
52
Change (1Y)
-48
Growth (1Y)
-48.00%
Revenue / Employee
$129,875
Profits / Employee
-$1,067,025
Market Cap
8.59M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 52 | -48 | -48.00% |
| Dec 31, 2023 | 100 | 6 | 6.38% |
| Dec 31, 2022 | 94 | 3 | 3.30% |
| Dec 31, 2021 | 91 | 26 | 40.00% |
| Dec 31, 2020 | 65 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 57 |
| NuCana | 22 |
| SeaStar Medical Holding | 19 |
| CalciMedica | 15 |
| Cardio Diagnostics Holdings | 15 |
| Iterum Therapeutics | 9 |
| TransCode Therapeutics | 7 |
| Ernexa Therapeutics | 6 |
BOLT News
- 10 days ago - Bolt Biotherapeutics to Participate in Upcoming March Conferences - GlobeNewsWire
- 4 months ago - Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027 - GlobeNewsWire
- 7 months ago - Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 10 months ago - Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 10 months ago - Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates - GlobeNewsWire
- 11 months ago - Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025 - GlobeNewsWire
- 11 months ago - Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025 - GlobeNewsWire